LISATA THERAPEUTICS, INC. Amortization of Deferred Charges
LISATA THERAPEUTICS, INC. (LSTA) reported Amortization of Deferred Charges of $600.00 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredCharges · last filed 2018-08-09
- LISATA THERAPEUTICS, INC. amortization of deferred charges for the quarter ending 2018-06-30 was $600.00K, a 100.00% increase year-over-year.
- LISATA THERAPEUTICS, INC. amortization of deferred charges for the quarter ending 2017-06-30 was $300.00K.
| Period end | Amortization of Deferred Charges 3 month | Amortization of Deferred Charges 6 month |
|---|---|---|
| 2018-06-30 | $600.00K 10-Q · filed 2018-08-09 | $1.30M 10-Q · filed 2018-08-09 |
| 2017-06-30 | $300.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |